| Revenue growth | 131% QoQ in Q4FY26 |
|---|---|
| Margins | Q4 EBITDA margin at 12%; PAT margin at 24% |
| Order book | ₹176cr total; ₹126cr in Life Sciences |
| Demand visibility | Enhanced via ₹176cr open order book |
| Management confidence | High; citing robust CDMO pipeline and audit successes |
Growth
Q4FY26 revenue grew 131% QoQ to ₹50.8cr. Annual FY26 revenue stood at ₹102.4cr, though company reported a full-year net loss of ₹28.8cr.
Outlook
Underway with 2x Life Sciences capacity expansion; order book improved by ₹60cr this quarter to total ₹176cr.
Risks
Logistics disruptions from Middle East conflict; temporary material cost impacts; one-time inventory adjustments by key customers.
Earnings Call filed with BSE, NSE: INOVSYNTH. Summary written with AI assistance from the document.
Innovassynth Technologies (India) Ltd: key numbers
- Share price
- ₹162.75
- Market cap
- ₹1,511 Cr
- Revenue (annual)
- ₹102.3 Cr
- Net profit (annual)
- ₹-28.79 Cr
- P/E (TTM)
- 145.0×Sector 37.0×
- Promoter holding
- 75.04%+1.34% QoQ
- FII holding
- 1.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Innovassynth Technologies (India) Ltd
All →Innovassynth Technologies (India) Annual Report
Innovassynth Technologies (India) Limited filed its Annual Report for FY 2025-26, including audited financial statements and notice convening the 18th Annual General Meeting.
Innovassynth Technologies (India) Annual General Meeting
Innovassynth Technologies will hold its 18th Annual General Meeting on September 30, 2026, via video conferencing. The remote e-voting cut-off date is September 23, 2026.
Innovassynth Technologies (India) Other Announcement
Innovassynth Technologies submitted the Monitoring Agency Report for the quarter ended June 30, 2026, confirming proceeds from the Rights Issue were utilized per the Letter of Offer.
Innovassynth Technologies (India) Investor Presentation: Key Takeaways
Innovassynth reported sharp Q1FY27 recovery with Revenue of ₹55.99 Cr and 27% EBITDA margin. Strategy focuses on CRDMO expansion in Life Sciences and Specialty Chemicals for US/EU markets.
Innovassynth Technologies (India) Q1 FY27 Results: Turns Profitable, Net Profit ₹6.7 Cr
Innovassynth Technologies (India) Ltd reported revenue from operations of ₹56 Cr (+355.3% YoY) and net profit of ₹6.7 Cr for Q1 FY27.
- Key figure
- Net profit ₹6.7 Cr
Innovassynth Technologies (India) Board Meeting Date
Innovassynth Technologies scheduled a board meeting for August 12, 2026, to approve unaudited standalone financial results for the quarter ended June 30, 2026.